IGHG3 and COVID-19: Although systems serological analysis points to enhanced IgG3 responses among individuals who ultimately developed COVID-19, future studies, in which larger amounts of samples were collected outside of a regulated phase 2b study, may identify associated unique IgG-subclass-specific, antibody glycan profiles that may shape IgG1 activity, the dominant antibody subclass in the blood and the lung87.